Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children

We describe the role of intravitreal anti-vascular endothelial growth factor (VEGF) agents in Coats' disease in children. In a prospective, interventional, non-randomized case series, three patients (three eyes) aged 16, seven and two years were diagnosed to have Coats' disease. In Case 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaul, Shalini, Uparkar, Mahesh, Mody, Kruti, Walinjkar, Jaydeep, Kothari, Mihir, Natarajan, S
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841382/
https://www.ncbi.nlm.nih.gov/pubmed/20029154
http://dx.doi.org/10.4103/0301-4738.58480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841382/
https://www.ncbi.nlm.nih.gov/pubmed/20029154
http://dx.doi.org/10.4103/0301-4738.58480

Ejemplares similares